Aims and Scope
Neuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG) , provides a forum for experimental and clinical investigations of the genetic, epigenetic, and protein signaling mechanisms underlying neurologic and psychiatric disorders. It is a resource for novel genetics studies of the heritable nature of psychiatric and other nervous system disorders, characterized at the molecular, cellular, or behavioral levels. Neuropsychiatric Genetics publishes eight times per year.

EDITOR-IN-CHIEF
Stephen V. Faraone (SUNY Upstate Medical University, Syracuse, New York, USA)
 
SENIOR EDITOR
Ming T. Tsuang (University of California, San Diego and Harvard University, Cambridge, Massachusetts, USA)
 
ASSOCIATE EDITORS
Ditte Demontis (Aarhus University, Denmark)
Stephen Glatt (SUNY Upstate Medical University, Syracuse, New York, USA)
Christel Middeldorp (University of Queensland, Children’s Health Queensland Hospital and Health Service, Australia and Vrije Universiteit Amsterdam, Netherlands)
Jordan W. Smoller (Harvard Medical School, Boston, Massachusetts, USA)


ASSISTANT EDITOR FOR COMMUNICATIONS
Karmel Choi (Massachusetts General Hospital and Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA)


EDITORIAL BOARD - FIELD EDITORS
Claiton Bau (Federal University of Rio Grande do Sul, Porto Alegre, Brazil)
Sarah Bergen (Karolinska Institutet, Stockholm, Sweden)
Dorret I. Boomsma (VU University, Amsterdam, The Netherlands)
Janita Bralten (Radboud University Medical Center, Nijmegen, The Netherlands)
Margit Burmeister (University of Michigan Medical School, Ann Arbor, Michigan, USA)
Murray Cairns (The University of Newcastle, Callaghan, Australia)
Wei J. Chen (National Taiwan University, Taipei, Taiwan)
Bru Cormand (University of Barcelona, Catalonia, Spain)
Aiden Corvin (Trinity College Dublin, Ireland)
Timothy J. Crow (Warneford Hospital, Oxford, United Kingdom)
Lea Davis (Vanderbilt University, Nashville, Tennessee, USA)
Ayman Fanous (Georgetown University, Washington, D.C., USA)
Joel Gelernter (Yale University School of Medicine, New Haven, Connecticut, USA)
David C. Glahn (Olin Neuropsychiatric Research Center and Yale University School of Medicine, New Haven, Connecticut, USA)
Peter Holmans (Cardiff University, Wales, United Kingdom)
Chunyu Liu (SUNY Upstate Medical University, Syracuse, New York, USA)
Wei Luo (Zhejiang University School of Medicine, Hangzhou, China)
Sarah Medland (QIMR Berghofer Medical Research Institute, Brisbane, Australia)
Jonathan Mill (Institute of Psychiatry, King's College London, United Kingdom)
Alexander B. Niculescu (Indiana University School of Medicine, Indianapolis, USA)
Vishwajit L. Nimgaonkar (University of Pittsburgh, Pennsylvania, USA)
Michael O’Donovan (School of Medicine Cardiff University, Wales, United Kingdom)
Carlos N. Pato (SUNY Downstate Medical Center, Brooklyn, New York, USA)
Michele Pato (SUNY Downstate Medical Center, Brooklyn, New York, USA)
Rob Philibert (University of Iowa, Iowa City, USA)
James B. Potash (Johns Hopkins School of Medicine, Baltimore, Maryland, USA)
Stephan Ripke (Charité - Universitätsmedizin, Berlin, Germany and Massachusetts General Hospital, Boston, USA and     Broad Institute of MIT and Harvard, Cambridge, USA)
Luis Augusto Rohde (Federal University of Rio Grande do Sul, Porto Alegre, Brazil)
Panos Roussos (Icahn School of Medicine at Mount Sinai, New York City, New York, USA)
Thomas Schulze (Institute of Psychiatric Phenomics and Genomics, Munich, Germany)
Alessandro Serretti (Institute of Psychiatry, Bologna, Italy
Debby Tsuang (University of Washington, Seattle, USA)
Shoji Tsuji (Niigata University, Japan)
George R. Uhl (National Institute on Drug Abuse, NIH, Baltimore, Maryland, USA)
Hiroshi Yoneda (Osaka Medical College, Japan)